Technology Driving Precision Medicine

Co-Located with Molecular Med TRI-CON Asia

May 28-31, 2013
Marina Bay Sands, Singapore

  • Css Template Preview 
  • Css Template Preview 
  • Css Template Preview 
  • Css Template Preview 
 

Bio-IT World Asia 2012 will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location. The Event provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process. This year's event will include dedicated tracks that include:

 

IT Infrastructure & the Cloud  IT Infrastructure and the Cloud  Drug Discovery Informatics  Drug Discovery Informatics 
Bioinformatics  Bioinformatics  NGS Data Management and Interpretation  NGS Data Management and Interpretation 

Keynote Presentations

 

The HIV/AIDS Pandemic and Prospects for Control
David D. Ho, M.D., Scientific Director & CEO, Aaron Diamond AIDS Research Center -Biography 

 

Bio-IT Trends from the TrenchesChris Dagdigian, Founding Partner and Director, Technology,BioTeam, Inc. -Biography 

 

Integrated Bioinformatics Solutions in Drug Discovery& Development
Yaron Turpaz, Ph.D., Vice President, Informatics
& Information Sciences, Research & Development Information, AstraZeneca Plc -Biography 

 

System Analysis of Complex Bacterial Communities
Peter Little, Ph.D., Professor, Associate Director, Singapore
Centre on Life Sciences Engineering; Director, Life Sciences Institute; Research Director, Office of Deputy President (Research & Technology), National University of Singapore -Biography 

Keynote Panel Discussion: Next-Gen Data Trends

 

Moderator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World -Biography 

 

Peter Little, Ph.D., Professor, Associate Director, SingaporeCentre on Life Sciences Engineering; Director, Life Sciences Institute; Research Director, Office of Deputy President (Research & Technology), National University of Singapore -Biography 

 

Yoshihide Hayashizaki, M.D., Ph.D., Director, RIKEN OmicsScience Center -Biography 

 

Seong-Jin Kim, Ph.D., President, CHA Research Institutes;Director, CHA Cancer Institute; Distinguished Professor, CHA University -Biography